Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 13.02
-0.01 (-0.08%)
Jun 1, 2026, 4:18 PM AEST
Telix Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Telix Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $23.30. The average 1-year stock price forecast is 78.96% higher than the current stock price, while the lowest is $18.00 (+38.25%) and the highest is $32.00 (+145.78%).
Price Target: $23.30 (+78.96%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Telix Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 10 | 10 | 8 | 8 |
| Buy | 4 | 5 | 4 | 4 | 5 | 5 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $30.00 | Buy | Maintains | $30.00 | +130.41% | May 25, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $22.40 | Buy | Maintains | $22.40 | +72.04% | May 24, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $19.00 | Buy | Maintains | $19.00 | +45.93% | May 8, 2026 |
| Citi | Citi | Buy Maintains $32.00 | Buy | Maintains | $32.00 | +145.78% | Apr 29, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $18.00 | Buy | Maintains | $18.00 | +38.25% | Apr 16, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.